Matches in Nanopublications for { ?s ?p "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP116295.RAAY3FNRa_DNfH_oE6Gt-_nb7t_dczteweEGiukP1yWwc130_assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP116295.RAAY3FNRa_DNfH_oE6Gt-_nb7t_dczteweEGiukP1yWwc130_provenance.
- NP116025.RA7VAG4WDwxc71v5Mc9Fb1Dn3s85v6ad4eEYulE8Cp3G4130_assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP116025.RA7VAG4WDwxc71v5Mc9Fb1Dn3s85v6ad4eEYulE8Cp3G4130_provenance.
- assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP179227.RArVirBs3VBKPMIREU1uMpxzszaoVXnnn9HzoHvsSX1NM130_assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179227.RArVirBs3VBKPMIREU1uMpxzszaoVXnnn9HzoHvsSX1NM130_provenance.
- NP235906.RAa2hx5ftvjxSLKQIgE8tMSR2sA7ie8VEQbYS2dRo5C7o130_assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235906.RAa2hx5ftvjxSLKQIgE8tMSR2sA7ie8VEQbYS2dRo5C7o130_provenance.
- assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP235907.RACk5AXEN0StkXaNpnWDzz84CrDR6fAHMEF0IUYTiP_X8130_provenance.
- NP179495.RAJ6uCW6YSwpNzwIdopS37mcMqsLMgz3NInqAi12KHmSE130_assertion description "[Of the informative human hepatocellular carcinoma samples 47.06% (8 of 17) demonstrated a gain of imprinting of IGF2, and 21.74% (5 of 23) of the informative HCC samples demonstrated a loss of imprinting of H19.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP179495.RAJ6uCW6YSwpNzwIdopS37mcMqsLMgz3NInqAi12KHmSE130_provenance.